IRB
Dopasi IRB Notification
DF_IRB_Application_Form_vF_210525
Institutional Review Board (IRB) Dopasi Foundation Pakistan
DOPASI Foundation is dedicated to maintaining high ethical standards in all research activities. In line with the directives of the National Bioethics Committee for Research of the Health Research Institute, DOPASI Foundation has an Institutional Review Board (IRB) to review and approve research involving human participants, ensuring compliance with both national and international ethical guidelines.
DOPASI Foundation is dedicated to maintaining high ethical standards in all research activities. In line with the directives of the National Bioethics Committee for Research of the Health Research Institute, DOPASI Foundation has an Institutional Review Board (IRB) to review and approve research involving human participants, ensuring compliance with both national and international ethical guidelines.
Our IRB carefully reviews research proposals to protect the rights, safety, and well-being of participants. If you are planning to conduct research in public health, biomedical, or social sciences, obtaining IRB approval is an essential part of the process.
To apply for ethical approval from DOPASI Foundation’s IRB:
• Download the IRB Application Form and Fee Challan (HYPERLINK)
• Review the submission guidelines carefully
• Submit your completed application, including proof of payment and all required documents, to (EMAIL ADDRESS)
• We accept applications throughout the year and aim to provide timely feedback to support your research.
• If you have any questions or need assistance, please contact us
Publications
DOPASI Foundation's commitment to research excellence is reflected in its growing body of published work across national and international established research platforms. With its own Institutional Review Board (IRB) ensuring ethical rigor, DOPASI has contributed original research articles, book reviews, short communications, and policy-relevant editorials to the global health and development discourse
Sr. | Title | Year | Link |
|---|---|---|---|
9 | Khetran MB, Kazi GN, Saeed Q, Eman K ul. Instituting reforms in the common management unit for Acquired Immunodeficiency Syndrome, Tuberculosis and Malaria. Pak J Public Health [Internet]. 2022 May 2 [cited 2026 Jun. 19];12(1):3-4. | 2022 | |
10 | Quadir A, Ghafoor A, Shah SK, Khokhar SH, Hadi H, Kazi GN, et al. Optimizing outcomes for drug resistant tuberculosis patients through provision of a comprehensive care package. Pak J Public Health [Internet]. 2022 May 2 [cited 2026 Jun. 19];12(1):8-12. | 2022 | |
11 | Kazi GN, Creswell J, Mohamud KB, Eman K ul. Tuberculosis in Pakistan. Pak J Public Health [Internet]. 2022 May 2 [cited 2026 Jun. 19];12(1):1-2. | 2022 | |
12 | Kazi GN, Eman K- ul-, Mohamud KB, Quadir A, Shah SK, Haq Z ul. Tuberculosis control in Pakistan: A decade (2011-2020) in review. Pak J Public Health [Internet]. 2022 May 2 [cited 2026 Jun. 19];12(1):17-22. | 2022 |
Reports
Our Progress reports serve as comprehensive records of our interventions, offering transparency, strategic insight, and accountability to donors, partners, auditors, and development practitioners. These documents reflect the scope and impact of our interventions—capturing progress updates, implementation outcomes, and financial performance. From program design to on-ground execution, each report is a window into our evolving practice, providing valuable reference points for stakeholders and contributing to shared learning in the development sector.
IEC Materials
We develop a diverse range of Information, Education and Communication (IEC) materials designed to inform, engage, and empower communities and stakeholders. These include training modules, manuals, toolkits, project profiles, and public service messages in the form of flyers and booklets—each developed under specific projects and aligned with our branding and communication guidelines. Additionally, tailored event materials such as banners, standees, and giveaways enhance our outreach efforts, ensuring consistent messaging and strong visual identity across all platforms.
Coming Soon
Coming Soon...
Description